57
Participants
Start Date
September 12, 2022
Primary Completion Date
March 1, 2027
Study Completion Date
March 1, 2028
Tovorafenib
Given orally
RECRUITING
NYU Langone Health, New York
RECRUITING
Children's Hospital of Philadelphia, Philadelphia
RECRUITING
John Hopkins University, Baltimore
RECRUITING
Duke University Medical Center, Durham
RECRUITING
University of Alabama at Birmingham, Birmingham
RECRUITING
Riley Hospital for Children at Indiana University Health, Indianapolis
RECRUITING
University of Michigan, Ann Arbor
RECRUITING
Children's Minnesota, Minneapolis
RECRUITING
Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
RECRUITING
St. Louis Children's Hospital Washington University, St Louis
RECRUITING
University of Utah, Salt Lake City
RECRUITING
Rady Children's Hospital/University of California, San Diego, San Diego
RECRUITING
University of California, San Francisco, San Francisco
RECRUITING
Dana-Farber/Boston Children's Harvard Medical School, Boston
Collaborators (1)
Day One Biopharmaceuticals, Inc.
INDUSTRY
Sabine Mueller, MD, PhD
OTHER